Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide
International Journal of Neonatal Screening · 16.12.2024 · 10 (4) · 82
DOI: 10.3390/ijns10040082 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 16.12.2024. Verfasst von Allysa M Kuypers und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Neth…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In The Netherlands, newborn screening (NBS) for tyrosinemia type 1 (TT1) uses dried blood spot (DBS) succinylacetone (SUAC) as a biomarker. However, high false-positive (FP) rates and a false-negative (FN) case show that the Dutch TT1 NBS protocol is suboptimal. In search of optimization options, we evaluated the protocols used by other NBS programs and their performance. We distributed an online survey to NBS program representatives worldwide (N = 41). Questions focused on the organization and performance of the programs and on changes since implementation. Thirty-three representatives completed the survey. TT1 incidence ranged from 1/13,636 to 1/750,000. Most NBS samples are taken between 36 and 72 h after birth. Most used biomarkers were DBS SUAC (78.9%), DBS Tyrosine (Tyr; 5.3%), or DBS Tyr with second tier SUAC (15.8%). The pooled median cut-off for SUAC was 1.50 µmol/L (range 0.3–7.0 µmol/L). The median cut-off from programs using laboratory-developed tests was significantly higher (2.63 µmol/L) than the medians from programs using commercial kits (range 1.0–1.7 µmol/L). The pooled median cut-off for Tyr was 216 µmol/L (range 120–600 µmol/L). Overall positive predictive values were 25.9% for SUAC, 1.2% for Tyr solely, and 90.1% for Tyr + SUAC. One FN result was reported for TT1 NBS using SUAC, while three FN results were reported for TT1 NBS using Tyr. The NBS programs for TT1 vary worldwide in terms of analytical methods, biochemical markers, and cut-off values. There is room for improvement through method standardization, cut-off adaptation, and integration of new biomarkers. Further enhancement is likely to be achieved by the application of post-analytical tools.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
- Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
- International Society for Neonatal Screening (ISNS) Office, 3721 CK Bilthoven, The Netherlands.
- Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
- Centre for Population Research, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
- Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
ORCID-Profile: Allysa M Kuypers, Marelle J Bouva, Anita Boelen, Konstantinos Petritis, C Austin Pickens, Francjan J van Spronsen, M Rebecca Heiner-Fokkema
Zitieren
APA
Kuypers, A. M., Bouva, M. J., Loeber, J. G., Boelen, A., Dekkers, E., Petritis, K., Pickens, C. A., The Isns Representatives, van Spronsen, F. J., & Heiner-Fokkema, M. R. (2024). Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide. International Journal of Neonatal Screening, 10(4), 82. https://doi.org/10.3390/ijns10040082
Vancouver
Kuypers AM, Bouva MJ, Loeber JG, Boelen A, Dekkers E, Petritis K, et al. Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide. International Journal of Neonatal Screening. 2024;10(4):82. doi:10.3390/ijns10040082
BibTeX
@article{Kuypers2024,
author = {Kuypers, Allysa M and Bouva, Marelle J and Loeber, J Gerard and Boelen, Anita and Dekkers, Eugenie and Petritis, Konstantinos and Pickens, C Austin and The Isns Representatives and van Spronsen, Francjan J and Heiner-Fokkema, M Rebecca},
title = {Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide},
journal = {International Journal of Neonatal Screening},
year = {2024},
volume = {10},
number = {4},
pages = {82},
doi = {10.3390/ijns10040082}
}
EUVIMED